资讯

GenHealth Creates 50M Public Patient Dataset

Million Medicare Patients. 10 Years. Unlimited Insights. VIENNA, VIRGINIA / ACCESS Newswire / September 4, 2025 / Today, we ...

Novo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive Appeal

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.